Literature DB >> 22782951

Protecting adults from influenza: tis the season to learn from the pandemic.

Anne Schuchat, Jacqueline M Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22782951      PMCID： PMC9009356          DOI： 10.1093/infdis/jis428

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

Authors:  Murdo Ferguson; George Risi; Matthew Davis; Eric Sheldon; Mira Baron; Ping Li; Miguel Madariaga; Louis Fries; Olivier Godeaux; David Vaughn
Journal:  J Infect Dis       Date:  2012-03-01       Impact factor: 5.226

2.  AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

Authors:  François Roman; Tejaswini Vaman; Froukje Kafeja; Emmanuel Hanon; Pierre Van Damme
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

3.  Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-11-05       Impact factor: 17.586

4.  Influenza immunization: Statement.

Authors:  Leroy E Burney
Journal:  Public Health Rep       Date:  1960-10       Impact factor: 2.792

Review 5.  The science behind preparing and responding to pandemic influenza: the lessons and limits of science.

Authors:  Anne Schuchat; Beth P Bell; Stephen C Redd
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

6.  Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.

Authors:  Nick J Andrews; Woolf T Walker; Adam Finn; Paul T Heath; Andrew C Collinson; Andrew J Pollard; Matthew D Snape; Saul N Faust; Pauline A Waight; Katja Hoschler; Liz Sheasby; Claire Waddington; Simon Kerridge; Jeremy Chalk; Amanda Reiner; Tessa John; Margaret Fletcher; Ruth Allen; Natalie Fineman; Su Wilkins; Michelle Casey; Louise Michaelis; Clarissa Oeser; Ifeanyichukwu Okike; Shamez Ladhani; Elizabeth Miller
Journal:  Vaccine       Date:  2011-08-27       Impact factor: 3.641

7.  Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.

Authors:  Karl G Nicholson; Keith R Abrams; Sally Batham; Tristan W Clark; Katja Hoschler; Wei Shen Lim; Marie-Jo Medina; Jonathan S Nguyen-Van-Tam; Robert C Read; Fiona C Warren; Maria Zambon
Journal:  Lancet Infect Dis       Date:  2010-12-16       Impact factor: 25.071

8.  Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

Authors:  Lisa A Jackson; Wilbur H Chen; Jack T Stapleton; Cornelia L Dekker; Anna Wald; Rebecca C Brady; Srilatha Edupuganti; Patricia Winokur; Mark J Mulligan; Harry L Keyserling; Karen L Kotloff; Nadine Rouphael; Diana L Noah; Heather Hill; Mark C Wolff
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

9.  Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Authors:  Eric Plennevaux; Eric Sheldon; Mark Blatter; Mary-Kate Reeves-Hoché; Martine Denis
Journal:  Lancet       Date:  2009-12-15       Impact factor: 79.321

10.  Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.

Authors:  Lamberto Manzoli; Corrado De Vito; Georgia Salanti; Maddalena D'Addario; Paolo Villari; John P A Ioannidis
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.